Cargando…
Cellular Cofactors of Lentiviral Integrase: From Target Validation to Drug Discovery
To accomplish their life cycle, lentiviruses make use of host proteins, the so-called cellular cofactors. Interactions between host cell and viral proteins during early stages of lentiviral infection provide attractive new antiviral targets. The insertion of lentiviral cDNA in a host cell chromosome...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420096/ https://www.ncbi.nlm.nih.gov/pubmed/22928108 http://dx.doi.org/10.1155/2012/863405 |
_version_ | 1782240801330298880 |
---|---|
author | Taltynov, Oliver Desimmie, Belete A. Demeulemeester, Jonas Christ, Frauke Debyser, Zeger |
author_facet | Taltynov, Oliver Desimmie, Belete A. Demeulemeester, Jonas Christ, Frauke Debyser, Zeger |
author_sort | Taltynov, Oliver |
collection | PubMed |
description | To accomplish their life cycle, lentiviruses make use of host proteins, the so-called cellular cofactors. Interactions between host cell and viral proteins during early stages of lentiviral infection provide attractive new antiviral targets. The insertion of lentiviral cDNA in a host cell chromosome is a step of no return in the replication cycle, after which the host cell becomes a permanent carrier of the viral genome and a producer of lentiviral progeny. Integration is carried out by integrase (IN), an enzyme playing also an important role during nuclear import. Plenty of cellular cofactors of HIV-1 IN have been proposed. To date, the lens epithelium-derived growth factor (LEDGF/p75) is the best studied cofactor of HIV-1 IN. Moreover, small molecules that block the LEDGF/p75-IN interaction have recently been developed for the treatment of HIV infection. The nuclear import factor transportin-SR2 (TRN-SR2) has been proposed as another interactor of HIV IN-mediating nuclear import of the virus. Using both proteins as examples, we will describe approaches to be taken to identify and validate novel cofactors as new antiviral targets. Finally, we will highlight recent advances in the design and the development of small-molecule inhibitors binding to the LEDGF/p75-binding pocket in IN (LEDGINs). |
format | Online Article Text |
id | pubmed-3420096 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-34200962012-08-27 Cellular Cofactors of Lentiviral Integrase: From Target Validation to Drug Discovery Taltynov, Oliver Desimmie, Belete A. Demeulemeester, Jonas Christ, Frauke Debyser, Zeger Mol Biol Int Review Article To accomplish their life cycle, lentiviruses make use of host proteins, the so-called cellular cofactors. Interactions between host cell and viral proteins during early stages of lentiviral infection provide attractive new antiviral targets. The insertion of lentiviral cDNA in a host cell chromosome is a step of no return in the replication cycle, after which the host cell becomes a permanent carrier of the viral genome and a producer of lentiviral progeny. Integration is carried out by integrase (IN), an enzyme playing also an important role during nuclear import. Plenty of cellular cofactors of HIV-1 IN have been proposed. To date, the lens epithelium-derived growth factor (LEDGF/p75) is the best studied cofactor of HIV-1 IN. Moreover, small molecules that block the LEDGF/p75-IN interaction have recently been developed for the treatment of HIV infection. The nuclear import factor transportin-SR2 (TRN-SR2) has been proposed as another interactor of HIV IN-mediating nuclear import of the virus. Using both proteins as examples, we will describe approaches to be taken to identify and validate novel cofactors as new antiviral targets. Finally, we will highlight recent advances in the design and the development of small-molecule inhibitors binding to the LEDGF/p75-binding pocket in IN (LEDGINs). Hindawi Publishing Corporation 2012 2012-08-07 /pmc/articles/PMC3420096/ /pubmed/22928108 http://dx.doi.org/10.1155/2012/863405 Text en Copyright © 2012 Oliver Taltynov et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Taltynov, Oliver Desimmie, Belete A. Demeulemeester, Jonas Christ, Frauke Debyser, Zeger Cellular Cofactors of Lentiviral Integrase: From Target Validation to Drug Discovery |
title | Cellular Cofactors of Lentiviral Integrase: From Target Validation to Drug Discovery |
title_full | Cellular Cofactors of Lentiviral Integrase: From Target Validation to Drug Discovery |
title_fullStr | Cellular Cofactors of Lentiviral Integrase: From Target Validation to Drug Discovery |
title_full_unstemmed | Cellular Cofactors of Lentiviral Integrase: From Target Validation to Drug Discovery |
title_short | Cellular Cofactors of Lentiviral Integrase: From Target Validation to Drug Discovery |
title_sort | cellular cofactors of lentiviral integrase: from target validation to drug discovery |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420096/ https://www.ncbi.nlm.nih.gov/pubmed/22928108 http://dx.doi.org/10.1155/2012/863405 |
work_keys_str_mv | AT taltynovoliver cellularcofactorsoflentiviralintegrasefromtargetvalidationtodrugdiscovery AT desimmiebeletea cellularcofactorsoflentiviralintegrasefromtargetvalidationtodrugdiscovery AT demeulemeesterjonas cellularcofactorsoflentiviralintegrasefromtargetvalidationtodrugdiscovery AT christfrauke cellularcofactorsoflentiviralintegrasefromtargetvalidationtodrugdiscovery AT debyserzeger cellularcofactorsoflentiviralintegrasefromtargetvalidationtodrugdiscovery |